Patent directory · USPTO A61K / A61P
Patents matching “Apellis Pharmaceuticals, Inc.”
24 pharma patents match "Apellis Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 24 pharmaceutical patents matching "Apellis Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12290566
Dosing regimens and related compositions and methods
granted -
US 12251395
RNAS for complement inhibition
granted -
US 11903994
Dosing regimens
granted -
US 11844841
Dosing regimens and related compositions and methods
granted -
US 11712460
Methods of treating chronic disorders with complement inhibitors
granted -
US 11661441
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
granted -
US 11510939
RNAs for complement inhibition
granted -
US 11407789
Cell-penetrating compstatin analogs and uses thereof
granted -
US 11338013
Combination therapy for C3 inhibition
granted -
US 11291407
Detection of high risk drusen
granted -
US 11292815
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
granted -
US 11040107
Dosing regimens and related compositions and methods
granted -
US 11013782
Methods of treating chronic disorders with complement inhibitors
granted -
US 11001610
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
granted -
US 10941184
Cell-penetrating compstatin analogs and uses thereof
granted -
US 10875893
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
granted -
US 10696718
Compstatin analogs for treatment of neuropathic pain
granted -
US 10407466
Methods of selecting compstatin mimetics
granted -
US 10308687
Cell-penetrating compstatin analogs and uses thereof
granted -
US 10125171
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
granted -
US 10039802
Methods of treating chronic disorders with complement inhibitors
granted -
US 10035822
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
granted -
US 9421240
Compstatin analogs for treatment of neuropathic pain
granted -
US 8580735
Local complement inhibition for treatment of complement-mediated disorders
granted